Clinical Trial Update: RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates RRx-001 for reducing oral mucositis in patients undergoing chemotherapy and radiation for head and neck cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• RRx-001

Snippet

Sponsor: EpicentRx, Inc. | Conditions: Oral Mucositis | Phase 2 | Status: RECRUITING